Doctor profile · Federal record
Dr. FLORENCE AKOUEGNON, CRNP
Primary Care Nurse Practitioner (CMS: NURSE PRACTITIONER) · Community Health Clinic/Center · Mental Health Clinic/Center (Including Community Mental Health Center) · Psychiatric/Mental Health Nurse Practitioner · Psychiatric/Mental Health Nurse Practitioner · Primary Care Nurse Practitioner · WILMINGTON, DE
- NPI 1083048748
- Accepts Medicare
- 8 yrs in practice
- Female
- Solo practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
5223 W WOODMILL DR STE 41
WILMINGTON, DE 198084068
(302) 516-7936
fax (302) 510-6964 - Additional location
-
2500 Wrangle Hill Rd Ste 205
Bear, DE 197013838
Credentials & registration
- NPI registered
- August 2013 — 13 yrs on file
- Profile last updated
- December 5, 2021
- Year of graduation
- 2018 — 8 yrs since
- Specialty taxonomy
- 363LP2300X — NUCC code
- State licenses (2)
- Delaware #LP-000135 · Delaware #LP-00013
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1083048748. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
168
Distinct HCPCS
2
Medicare allowed
$18,218
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 156 | 35 | $106 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 12 | 12 | $141 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 84. This provider delivers 2.0× the peer median.Open Payments
Industry payments received
All-time total
$1,960
Transactions
53
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 24 | $744.16 | |
| Neurocrine Biosciences, Inc. | 8 | $470.99 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $169.16 | |
| Axsome Therapeutics, Inc. | 3 | $164.15 | |
| Abbott Laboratories | 1 | $79.78 | |
| Teva Pharmaceuticals USA, Inc. | 2 | $73.23 | |
| Alkermes, Inc. | 2 | $45.10 | |
| ABBVIE INC. | 2 | $40.47 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $39.74 | |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33.75 | |
| Smith+Nephew, Inc. | 1 | $24.82 | |
| Indivior Inc. | 1 | $22.35 | |
| Almatica Pharma LLC | 1 | $18.44 | |
| Janssen Pharmaceuticals, Inc | 1 | $17.63 | |
| Braeburn Inc. | 1 | $16.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
342
Patients
25
Total drug cost
$4,377
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Gabapentin | Generic | 30 | 12 | $432 |
| Quetiapine Fumarate | Generic | 29 | 0 | $338 |
| Atorvastatin Calcium | Generic | 28 | 13 | $621 |
| Lorazepam | Generic | 27 | 0 | $164 |
| Hydrochlorothiazide | Generic | 26 | 0 | $163 |
| Clonazepam | Generic | 23 | 0 | $302 |
| Mirtazapine | Generic | 23 | 0 | $267 |
| Amlodipine Besylate | Generic | 22 | 0 | $40 |
| Aripiprazole | Generic | 22 | 0 | $259 |
| Omeprazole | Generic | 20 | 0 | $29 |